PTCH1 and neoplasm: The D362Y mutation seen in this study in sample FICJG, is in the fourth transmembrane domain of PTCH1 and has been previously seen as a loss-of-function germline mutation in a patient with Gorlin syndrome, predisposing to neoplasms (numbered D513Y due to different transcript) [75].